1. Home
  2. IMRN vs HIHO Comparison

IMRN vs HIHO Comparison

Compare IMRN & HIHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • HIHO
  • Stock Information
  • Founded
  • IMRN 1994
  • HIHO 1990
  • Country
  • IMRN Australia
  • HIHO Hong Kong
  • Employees
  • IMRN N/A
  • HIHO N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • HIHO Industrial Machinery/Components
  • Sector
  • IMRN Health Care
  • HIHO Industrials
  • Exchange
  • IMRN Nasdaq
  • HIHO Nasdaq
  • Market Cap
  • IMRN 10.1M
  • HIHO 8.2M
  • IPO Year
  • IMRN N/A
  • HIHO 1996
  • Fundamental
  • Price
  • IMRN $1.75
  • HIHO $1.80
  • Analyst Decision
  • IMRN Strong Buy
  • HIHO
  • Analyst Count
  • IMRN 1
  • HIHO 0
  • Target Price
  • IMRN $5.00
  • HIHO N/A
  • AVG Volume (30 Days)
  • IMRN 13.7K
  • HIHO 2.1K
  • Earning Date
  • IMRN 04-15-2025
  • HIHO 01-21-2025
  • Dividend Yield
  • IMRN N/A
  • HIHO 6.67%
  • EPS Growth
  • IMRN N/A
  • HIHO N/A
  • EPS
  • IMRN N/A
  • HIHO N/A
  • Revenue
  • IMRN $4,048,286.00
  • HIHO $7,345,000.00
  • Revenue This Year
  • IMRN N/A
  • HIHO N/A
  • Revenue Next Year
  • IMRN N/A
  • HIHO N/A
  • P/E Ratio
  • IMRN N/A
  • HIHO N/A
  • Revenue Growth
  • IMRN 82.90
  • HIHO 11.36
  • 52 Week Low
  • IMRN $1.70
  • HIHO $1.70
  • 52 Week High
  • IMRN $3.09
  • HIHO $2.88
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 41.07
  • HIHO 41.05
  • Support Level
  • IMRN $1.73
  • HIHO $1.83
  • Resistance Level
  • IMRN $2.09
  • HIHO $1.88
  • Average True Range (ATR)
  • IMRN 0.14
  • HIHO 0.03
  • MACD
  • IMRN 0.00
  • HIHO -0.01
  • Stochastic Oscillator
  • IMRN 10.26
  • HIHO 0.00

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.

Share on Social Networks: